ADHD and Suicide: Key Risk Factors, Clinical Insights, and Treatment Strategies

Credit

Speaker

Amelia Kelley, PhD Related seminars and products

---

Dr. Amelia Kelley is a trauma-informed therapist, researcher, and educator specializing in mental health, neurodiversity, trauma recovery, and nervous-system regulation across the lifespan. She is the author of Powered by ADHD, Surviving Suicidal Ideation, and several other books, and the founder of the Powered by ADHD community and support group. She is also the owner of Kelley Counseling & Wellness, serving neurodivergent and highly sensitive individuals of all ages.

Her work has been featured in ADDitude, SiriusXM Doctor Radio, NPR, The Chicago Tribune, Parade, Healthline, HuffPost, and Psychology Today. A TED speaker and 2025 TED Editor’s Pick, Dr. Kelley is a national advocate for suicide prevention and early mental health screening in schools, supporting all children — including neurodivergent youth — through proactive, prevention-focused care. She teaches internationally on trauma, empowerment-based therapy, ADHD, and embodied regulation, and is the developer of the Women-Centered ADHD Treatment Model (W-CAT), advancing more accurate and compassionate mental health treatment.
 

Speaker Disclosures:
Financial: Amelia Kelley maintains a private practice and has an employment relationship with the Art Therapy Institute. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Amelia Kelley has no relevant non-financial relationships.

Additional Info

Access never expires for this product.

For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com.

Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info

For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com.

Objectives

1. Assess suicide risk across the continuum of suicidality (passive, active, chronic, acute) using demographics, psychosocial, and ADHD-specific  factors, including substance use, rejection sensitivity, and ADHD presentation.
2. Differentiate suicidal behavior from non-suicidal self-injury (NSSI), identify common myths about suicide, and recognize how ADHD subtypes influence risk expression and clinical presentation.
3. Apply ADHD-informed grounding and regulation skills, assessment questions, and treatment strategies, including implementing an appropriate crisis response and safety plan when acute risk is identified

Outline

What Do We Know About Suicide? Understanding Baseline Risk

• Demographic and geographic risk patterns
• Methods, lethality, and access
• Firearms, impulsivity, and escalation
• Developmental and relational risk factors (including ADHD and chronic correction)
• The continuum of suicidality: passive → active → chronic
• Clinical takeaway
  • Why access, development, and chronic emotional pain often matter more than stated intent.

Combating the 10 Common Myths About Suicide

• “Talking about suicide causes it.”
• “People who self-harm want to die.”
• “Suicide is always impulsive.”
• “If someone is serious, there will be clear warning signs.”
• “People who talk about suicide are just seeking attention.”
• “Improvement means the risk has passed.”
• “Only people with severe mental illness die by suicide.”
• “Strong, successful, or high-functioning people don’t attempt suicide.”
• “Once someone decides, nothing can stop them.”
• “Suicide risk can be accurately predicted with a single assessment.”
• Clinical takeaway
  • How myths interfere with assessment and safety planning

Special Populations at Elevated Risk

• Mental illness
• Veterans
• LGBTQ+ populations
• Gender-based risk patterns
• Youth & adolescents
• Neurodiverse individuals
• Clinical takeaway
  • Shared and distinct risk pathways

Distinguishing Suicide from Non-Suicidal Self-Injury (NSSI)

• Functional drivers of NSSI (regulation, grounding, stimulation)
• Emotional regulation vs. death intent
• ADHD-specific contributors to NSSI, including impulsivity, interoceptive confusion, and sensory dysregulation
• Sensory overload vs. sensory under-arousal as NSSI pathways
• Clinical takeaway
  • Accurate differentiation prevents both minimization and unnecessary escalation.

ADHD & Suicide: A Clinically Underappreciated Relationship

• Suicidality among individuals with ADHD
• Prevalence of ADHD in suicidal and  high-risk populations
• ADHD as an addictive suicide risk – independent of mood disorders
• The compounding impact of trauma, substance use, and rejection sensitivity
• Clinical takeaway
  • How ADHD alone elevates risk – even when mood symptoms are treated.

ADHD, Substance Use, and Suicide Risk

• Dopamine dysregulation and reduced reward sensitivity in ADHD
• Impulsivity and disinhibition under emotional distress
• Self-medication and emotional avoidance through substances
• Substance use as a suicide risk amplifier
• Clinical takeaway
  • Substance use increases suicide risk in ADHD by lowering inhibition and intensifying impulsivity – underscoring the need to screen beyond the primary diagnosis.

Framing Risk Using the Interpersonal-Psychological Theory of Suicide

• Thwarted belongingness in ADHD (rejection sensitivity, social rupture)
• Perceived burdensomeness (chronic “too much/not enough” messaging)
• Acquired capability (pain tolerance, risk exposure, impulsivity)
• Clinical takeaway
  • Why ADHD aligns with this model

Suicide Assessment: Questions, Risks, and Limitations

• ADHD-informed assessment questions
• What assessment tools can and cannot do
• Ethical and clinical limitations
• Acute crisis response: best-practice steps and higher level of care decisions
• Clinical takeaway
  • Assessment is ongoing – and when acute risk is present, best practice requires immediate safety actions, documentation, and appropriate escalation of care.

Emergency Grounding & Regulation Skills (Brief, Practical Tools)

• Rapid nervous system regulation during suicidal or impulsive spikes
• Grounding for ADHD-related impulsivity and sensory overload
• Demonstration: centering and orienting as immediate stabilization tools
• Contraindications: when mindfulness or meditation may increase risk (SI, dissociation, ADHD-specific challenges)
• When skills support safety – and when higher-level intervention is required
• Clinical takeaway
  • Stabilization supports safety planning but never replaces risk or intervention.

Treatment Implications & Suicide Prevention in ADHD

• The impact of treating ADHD on suicidality and NSSI
• Meeting patients where they are (attention, shame, overwhelm)
• Protective factors and community connection as buffers against suicide risk
• Collaborative safety planning as an ongoing, living intervention
• Integrating safety into long-term ADHD-informed care
• Clinical takeaway
  • Suicide prevention in ADHD is built through accurate treatment, strengthened protective factors, and sustained connection – not fear-based intervention alone.

Resources

• Crisis resources
• ADHD-specific supports
• Clinician tools and references

Target Audience

• Licensed Clinical/Mental Health Counselors 
• Psychologists 
• Marriage & Family Therapists 
• Social Workers 
• Physicians